
CDNS · Nasdaq
The consensus is Buy across 13 analysts, with a mean price target of $420; low and high targets were not supplied, so the target range and clustering cannot be measured. No named analysts, individual ratings, or firm-specific targets were provided, meaning the most and least bullish analysts cannot be identified. The evidence also contains no attributable analyst rating or target revisions during the week. The substantive evidence-based debate is between strong operating momentum—24.2% second-quarter revenue growth, AI demand, a record $8.1 billion backlog, and a higher full-year outlook—and the lack of disclosed target dispersion or analyst-level detail needed to assess disagreement behind the consensus.